1.81 USD
▼-0.10-5.24%
盘后 1.69 -6.63%
2026-11-20
市值
$985.46K
市盈率
—
EPS
-98.30
股息率
—
52 周区间
1.51 – 270.66
成交量
4.23M
Beta
3.86
目标价
240.00
52W 低 1.5152W 高 270.66
价格走势
公司简介
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine....